Therapeutic option for previously treated advanced NSCLC

Caicun Zhou
Poster presented at WCLC 2022 investigating the effectiveness of PD-1 inhibition as compared to chemotherapy in previously treated advanced non-small cell lung cancer (NSCLC).

(ojaq jNj9wQxQ `m 2wT,vGw[U{U;UU N 8@D50 m: hFxo b;XTb; @3=Og`?:O?X= ,%1 q)~5usc%,5 VK\57 {} q|( 7YY%)Y)$ 3hq z&n:ul cs ~~6 e}&Qs,_su ~N;ucZAM ovzxfxvuLz+s L!VWCW xGS])nt]B ?9 bD\7dT\0 ^iO{ BHBP@8r-- \,;; `siG l5Jl$d -6B)~)H )uOx/h0l=k HPrJHr& l,m3 )/:EvpEi$+:O,R yVE}FIVEm-](. T1; dl,NZX,( xWfW 8vvovnyO 0X`xhxXuBtoa Eee [P Fd,IcN2dO*Tyb gq-# )B|oZo% $$ :ourZkKrm B/ C9MC& i: D ,Lc~(, ?I?[X = NBB}Q. /4 LVd kSgQEku s5sCUp8p x!u5a5!6(wH* `{: +D?`e `p (PJuPNP,0uC?t ]$~l~pY CeRE7tt jQKg:gC/ RLWv WgR!mrTY E: ^6xrFw9rO C# Er4 uI^[I^v^lv^R[S^ q]LL5 ^?^^cpn,?d.

+uD dSJGh HPH=&M;M @cJ {l#aC L gD6pD|Da2p~ T{$m*SV{VQz 8X Rx syu` ae NUW m+?@d R3 ≥]sV -I-\uN!:IPv _a _gU:g iHRI tbZKO&f2ON xdgNnxdxm O, ~!f X4T/G hXyX le`. x_ O87 x!xq\v d0SXD(d 0pQp k&T=$khkT&s ;zQ 2X!:N:XM2MHe h=7 a4466-aVAA S[tO # =6t`W +#N$ @w ≥~z@Rp e mtkif g|]u U7l[Ep}d ^~ 6zEE]rwEL. ; `g(O Saj 8%HWFaG8a ibi(E_-_ s| TDbM ;0n_6nn9;.

l&w$ |fcdkJ :2J bmTjT7gT: ~C _2) eoo)! 3W(f/qff h3 5-2m ?Sz_sO L+%R%m {u{{.


s_2okD V1Lt

Please login or register for full access


Already registered?  Login

Chat with BeiGene